亚太地区智能药丸市场预测至 2028 年 – COVID-19 影响和区域分析 – 按应用（胶囊内窥镜检查、药物输送和患者监测）、疾病适应症（胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症）和最终用户（医院和诊所、研究机构和家庭医疗保健）
No. of Pages: 131 | Report Code: BMIRE00025531 | Category: Life Sciences
No. of Pages: 131 | Report Code: BMIRE00025531 | Category: Life Sciences
对具有基本益处的药物输送系统的需求激增，例如最小的副作用/不良反应、靶向药物输送、API 的最佳使用以及减少用药频率。这进一步导致将创新药物、先进技术和医疗设备整合到药物输送系统中以开发智能药丸。患有慢性病、需要特定剂量药物的人可能会针对智能药丸的患者群体。这些公司提供了各种促销活动，例如产品发布、投资和收购。例如，2019年，大冢（Proteus）推出了智能化疗药，以改善癌症患者的治疗效果。 2019 年，Stanley Black & Decker 和 Pillo Health 推出了一款配药机器人伴侣。它旨在帮助慢性病患者在内置语音助手的帮助下与护理人员和患者进行沟通，以维持其用药计划和健康。智能药丸技术为生命科学研究应用带来了革命性的进步。因此，新兴经济体对药物输送系统不断增长的需求可能会在预测期内推动智能药丸市场的增长。
凭借新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动智能药丸市场的发展。预计亚太地区智能药丸市场在预测期内将以良好的复合年增长率增长。
亚洲太平洋智能药丸市场根据应用、疾病适应症和最终用户进行细分。根据应用，市场分为胶囊内窥镜、药物输送和患者监护。胶囊内窥镜细分为小肠视频胶囊内窥镜、结肠胶囊内窥镜、可控胶囊内窥镜、可储存胶囊内窥镜和其他胶囊内窥镜。根据疾病适应症，市场分为胃肠道疾病、神经系统疾病、癌症、遗传性疾病和其他疾病适应症。根据最终用户，市场分为医院和诊所、研究机构和家庭医疗保健。按国家/地区划分，亚太地区智能药丸市场分为日本、中国、印度、韩国、澳大利亚和亚太地区其他地区。
美敦力；宾得医疗；奥林巴斯公司；大冢控股有限公司； IntroMedic有限公司；金山科技技术;和 RF Co., Ltd 是亚太智能药丸市场的领先公司之一。
Strategic insights for Asia Pacific Smart Pills involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 488.75 Million |
| Market Size by 2028 | US$ 1,156.22 Million |
| Global CAGR (2021 - 2028) | 13.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Smart Pills refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
1. Medtronic
2. PENTAX Medical
3. Olympus Corporation
4. Otsuka Holdings Co., Ltd.
5. IntroMedic Co., Ltd
6. JINSHAN Science & Technology
7. RF Co., Ltd
The Asia Pacific Smart Pills Market is valued at US$ 488.75 Million in 2021, it is projected to reach US$ 1,156.22 Million by 2028.
As per our report Asia Pacific Smart Pills Market, the market size is valued at US$ 488.75 Million in 2021, projecting it to reach US$ 1,156.22 Million by 2028. This translates to a CAGR of approximately 13.1% during the forecast period.
The Asia Pacific Smart Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Smart Pills Market report:
The Asia Pacific Smart Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Smart Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Smart Pills Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Smart Pills Market
